Aarti Pharmalabs Ltd. (APL)
Prasad Pamarthi has extensive experience in global business development and project management within the pharmaceutical and biotechnology sectors. Currently serving as the Global CDMO Business Development Lead for Small Molecule Drug Substances at Aarti Pharmalabs Limited since February 2022, Prasad focuses on building strategic partnerships and enhancing the company's branding while managing client relationships. Prior to this role, Prasad was the General Manager for Global Business Development & Project Management at Raghava Life Sciences, overseeing sales and marketing for CDMO and APIs. Earlier positions include significant roles at GVK BIO, handling diverse markets across North America, APAC, and Europe, and contributing to client relationship management and project execution. Prasad holds a Master's degree in Organic Chemistry and an MBA in International Business, along with a Bachelor's degree in Science.
This person is not in any offices
Aarti Pharmalabs Ltd. (APL)
1 followers
Aarti Pharmalabs Limited (APL) is a leading Indian manufacturer of Pharmaceuticals and Nutraceuticals with a global footprint. We deliver process chemistry expertise, with a scale-up engineering competence, regulatory support and long-term supply by maintaining quality and timely delivery to create a sustainable future. Over the last two decades, APL serving global clients with top notch scientific knowledge, industry experts, state-of-the-art R&D and USFDA, EUGMP, EDQM, KFDA inspected manufacturing facilities. We manufacture Generic APIs, Intermediates and Xanthine derivatives. We offer CDMO services for small molecules drug substances (API/NCE/RSM/Intermediate) process development and manufacturing focusing on Ph-I/II/III, launch and commercial phase projects for Innovator Pharmaceutical and Biotech companies. We have been helping our clients to bring their molecules to market quickly and efficiently from clinical development through commercial stage manufacturing. We have dedicated facilities to manufacture HPAPIs, Corticosteroids, Cytotoxic and Oncology products. We are one of the preferred partner for Beverages and Nutraceuticals Industries for our flagship product ‘Caffeine’.